Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model
Qian Shi, Cheng Chang, Afaf Saliba, et al.
Journal of Neuroscience (2022) Vol. 42, Iss. 27, pp. 5294-5313
Open Access | Times Cited: 75

Showing 26-50 of 75 citing articles:

Celastrol Ameliorated Alzheimer’s Disease in Mice by Enhancing TBX21/TREM2 Expression in Microglia and Inhibiting Tau Phosphorylation
Fanfan Cao, Pan Zhang, Yongbin Chi, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
A Novel Mutation in CNTNAP1 Gene Causes Disorganization of Axonal Domains, Hypomyelination and Severe Neurological Deficits
Lacey B. Sell, Claus Zabel, Sabine Grønborg, et al.
Journal of Neuroscience Research (2025) Vol. 103, Iss. 4
Closed Access
Drugs, clocks and exercise in ageing: hype and hope, fact and fiction
Regula Furrer, Christoph Handschin
The Journal of Physiology (2022) Vol. 601, Iss. 11, pp. 2057-2068
Open Access | Times Cited: 17
Neuroimmune mechanisms underlying Alzheimer’s disease: Insights into central and peripheral immune cell crosstalk
Yuqing Liu, Yejun Tan, Zheyu Zhang, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101831-101831
Closed Access | Times Cited: 17
Trem2 deficiency attenuates microglial phagocytosis and autophagic‐lysosomal activation in white matter hypoperfusion
Xiao‐Wei Pang, Yun‐Hui Chu, Luo‐Qi Zhou, et al.
Journal of Neurochemistry (2023) Vol. 167, Iss. 4, pp. 489-504
Closed Access | Times Cited: 10
Monoclonal antibody therapy for Alzheimer's disease focusing on intracerebral targets
Xiaolei Gu, Qi Long, Qing Qi, et al.
BioScience Trends (2024) Vol. 18, Iss. 1, pp. 49-65
Open Access | Times Cited: 3
The proteomic landscape of microglia in health and disease
Emma Davis, Amy Lloyd
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 3
Age-related driving mechanisms of retinal diseases and neuroprotection by transcription factor EB-targeted therapy
Samuel Abokyi, Dennis Y. Tse
Neural Regeneration Research (2024) Vol. 20, Iss. 2, pp. 366-377
Open Access | Times Cited: 3
Hidden role of microglia during neurodegenerative disorders and neurocritical care: A mitochondrial perspective
Xinrun Wang, Jiyun Hu, Shucai Xie, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113024-113024
Closed Access | Times Cited: 3
Role of trigger receptor 2 expressed on myeloid cells in neuroinflammation－neglected multidimensional regulation of microglia
Xin Zhang, Xue Chen, Ling Zhang, et al.
Neurochemistry International (2023) Vol. 171, pp. 105639-105639
Closed Access | Times Cited: 9
Fresh Gastrodia elata Blume alleviates simulated weightlessness-induced cognitive impairment by regulating inflammatory and apoptosis-related pathways
Yiwen Zhang, Hong Huang, Caihong Yao, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Current Advances in Mitochondrial Targeted Interventions in Alzheimer’s Disease
Tiago Siqueira de Sousa, Paula I. Moreira, Susana Cardoso
Biomedicines (2023) Vol. 11, Iss. 9, pp. 2331-2331
Open Access | Times Cited: 8
Proinflammatory S100A9 stimulates TLR4/NF-κB signaling pathways causing enhanced phagocytic capacity of microglial cells
Xiaoyin Zhang, Dan Sun, Xin Zhou, et al.
Immunology Letters (2023) Vol. 255, pp. 54-61
Closed Access | Times Cited: 7
Mouse models of human CNTNAP1-associated congenital hypomyelinating neuropathy and genetic restoration of murine neurological deficits
Cheng Chang, Lacey B. Sell, Qian Shi, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113274-113274
Open Access | Times Cited: 7
Potential Alzheimer’s disease drug targets identified through microglial biology research
Izabela Lepiarz‐Raba, Taufik Hidayat, Anthony J. Hannan, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 5, pp. 587-602
Closed Access | Times Cited: 2
Rethinking the role of microglia in obesity
Giulia Cutugno, E. Kyriakidou, Agnès Nadjar
Neuropharmacology (2024) Vol. 253, pp. 109951-109951
Open Access | Times Cited: 2
Microglia either promote or restrain TRAIL-mediated excitotoxicity caused by Aβ1−42 oligomers
Jian Zou, Elizabeth McNair, S Decastro, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Treating Alzheimer’s Disease: Focusing on Neurodegenerative Consequences
Miao‐Kun Sun, Daniel L. Alkon
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. s1, pp. S263-S274
Closed Access | Times Cited: 2
The deficient CLEC5A ameliorates the behavioral and pathological deficits via the microglial Aβ clearance in Alzheimer’s disease mouse model
Yu-Yi Lin, Wen‐Han Chang, Shie‐Liang Hsieh, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Cellular senescence in Alzheimer’s disease: from physiology to pathology
Jing Zhu, Chongyun Wu, Luodan Yang
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Modifying Dietary Protein Impacts mTOR Signaling and Brain Deposition of Amyloid β in a Knock-In Mouse Model of Alzheimer Disease
Julien Bensalem, Leanne K. Hein, Sofia Hassiotis, et al.
Journal of Nutrition (2023) Vol. 153, Iss. 5, pp. 1407-1419
Open Access | Times Cited: 6
Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases
Ashley L. Reed, Wayne Mitchell, Andrei T. Alexandrescu, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 6
Study on the Pharmacological Mechanism of Icariin for the Treatment of Alzheimer’s Disease Based on Network Pharmacology and Molecular Docking Techniques
Dongwei Wang, Ji‐long Zheng, Xingsheng Sun, et al.
Metabolites (2023) Vol. 14, Iss. 1, pp. 1-1
Open Access | Times Cited: 4
Translational control of microglial inflammatory and neurodegenerative responses
Sara Bermudez, Jung‐Hyun Choi, Jacob W. Vogel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Exploring the Roles of Key Mediators IKBKE and HSPA1A in Alzheimer’s Disease and Hepatocellular Carcinoma through Bioinformatics Analysis
Yiying Wang, Yakun Yang, Ce Liang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6934-6934
Open Access | Times Cited: 1

Scroll to top